
Sign up to save your podcasts
Or
On this episode of The Medical Alley Podcast, we have a conversation with Wayne Paterson, CEO and Managing Director of Anteris Technologies.
In late December of 2024, Anteris Technologies launched an IPO to support the development of DurAVR, a Transcatheter Heart Valve (THV) designed to treat aortic stenosis. Wayne discusses the IPO and DurAVR’s development, the future of Anteris Technologies, and why the company has chosen Minnesota as the site of its global headquarters.
Send us a message!
Follow Medical Alley on social media on LinkedIn, Facebook, X and Instagram.
5
1818 ratings
On this episode of The Medical Alley Podcast, we have a conversation with Wayne Paterson, CEO and Managing Director of Anteris Technologies.
In late December of 2024, Anteris Technologies launched an IPO to support the development of DurAVR, a Transcatheter Heart Valve (THV) designed to treat aortic stenosis. Wayne discusses the IPO and DurAVR’s development, the future of Anteris Technologies, and why the company has chosen Minnesota as the site of its global headquarters.
Send us a message!
Follow Medical Alley on social media on LinkedIn, Facebook, X and Instagram.
3,007 Listeners
38,599 Listeners
38,167 Listeners
22,132 Listeners
47 Listeners
6,793 Listeners
43,466 Listeners
10,665 Listeners
111,083 Listeners
55,867 Listeners
9,215 Listeners
319 Listeners
31 Listeners
15,313 Listeners
12,303 Listeners